BioCentury
ARTICLE | Financial News

D. Western planning IPO

September 22, 2009 1:11 AM UTC

D. Western Therapeutics Institute Inc. (Nagoyashi, Japan) is planning to sell 3 million shares in an IPO. The offering is being underwritten by Nomura; Mitsubishi UFJ; Takagi; SBI Securities; Tokai Tokyo; Mizuho; Nikko Citigroup; Ichiyoshi; and Mizuho Investors. D. Western, which expects to go public on Oct. 23, is developing protein kinase inhibitors for cardiovascular, ophthalmic and neurology diseases and cancer.

Last week, cancer company CanBas Co. Ltd. (Tokyo:4575) raised Y1.3 billion ($14.8 million) through the sale of 640,000 shares at Y2,100 in an IPO underwritten by Mitsubishi UFJ; Mizuho; Ichiyoshi; JPMorgan; Mizuho Investors; Takagi; aizawa; Toyo; Shizugin; and Marusan. The price values CanBas at Y5.9 billion ($64.8 million). ...